#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4729140	B	Inhibition of recombinant full-length Plasmodium falciparum 3D7 CLK3 using ULight-labelled CFFKNIVTPRTPPPSQGK as substrate measured after 1 hr by TR-FRET assay	Plasmodium falciparum 3D7	15		assay format	Scientific Literature
2.	ALA4729141	F	Antimalarial activity against chloroquine-sensitive synchronized ring stage of Plasmodium falciparum 3D7 incubated for 48 to 52 hrs by SYBR green 1 dye based assay	Plasmodium falciparum	16		organism-based format	Scientific Literature
3.	ALA4729142	P	Distribution coefficient, log D of the compound at pH 7.4 by HPLC method		15		small-molecule physicochemical format	Scientific Literature
4.	ALA4729143	A	Intrinsic clearance in CD1 mouse liver microsomes assessed per gram of tissue at 1 uM measured up to 30 mins in presence of NADPH by HPLC analysis	Mus musculus	15		microsome format	Scientific Literature
5.	ALA4729144	F	Antimalarial activity against chloroquine-sensitive synchronized ring stage of Plasmodium falciparum 3D7 harboring CLK3 G449P mutant incubated for 48 to 52 hrs by SYBR green 1 dye based assay	Plasmodium falciparum	2		organism-based format	Scientific Literature
6.	ALA4729145	F	Selectivity ratio of EC50 for antimalarial activity against chloroquine-sensitive synchronized ring stage of Plasmodium falciparum 3D7 harboring CLK3 G449P mutant to EC50 for antimalarial activity against chloroquine-sensitive synchronized ring stage of Plasmodium falciparum 3D7	Plasmodium falciparum	2		assay format	Scientific Literature
7.	ALA4729146	F	Antimalarial activity against Plasmodium falciparum isolate GB0006 assessed as reduction in parasitemia at 1 to 10 times EC50 supplemented with fresh medium containing compounds every 24 hrs for 72 hrs relative to control	Plasmodium falciparum	2		organism-based format	Scientific Literature
8.	ALA4729147	F	Antimalarial activity against Plasmodium falciparum isolate GB0004 assessed as reduction in parasitemia at 1 to 10 times EC50 supplemented with fresh medium containing compounds every 24 hrs for 72 hrs relative to control	Plasmodium falciparum	2		organism-based format	Scientific Literature
9.	ALA4729148	F	Antimalarial activity against Plasmodium falciparum isolate GB0021 assessed as reduction in parasitemia at 1 to 10 times EC50 supplemented with fresh medium containing compounds every 24 hrs for 72 hrs relative to control	Plasmodium falciparum	2		organism-based format	Scientific Literature
10.	ALA4729149	F	Antimalarial activity against Plasmodium falciparum isolate GB0048 assessed as reduction in parasitemia at 1 to 10 times EC50 supplemented with fresh medium containing compounds every 24 hrs for 72 hrs relative to control	Plasmodium falciparum	2		organism-based format	Scientific Literature
11.	ALA4729150	F	Antimalarial activity against Plasmodium falciparum isolate GB0071 assessed as reduction in parasitemia at 1 to 10 times EC50 supplemented with fresh medium containing compounds every 24 hrs for 72 hrs relative to control	Plasmodium falciparum	2		organism-based format	Scientific Literature
12.	ALA4729151	F	Antimalarial activity against Plasmodium falciparum isolate GB0087 assessed as reduction in parasitemia at 1 to 10 times EC50 supplemented with fresh medium containing compounds every 24 hrs for 72 hrs relative to control	Plasmodium falciparum	2		organism-based format	Scientific Literature
13.	ALA4729158	F	Antimalarial activity against Plasmodium falciparum isolate GB0020 assessed as reduction in parasitemia at 1 to 10 times EC50 supplemented with fresh medium containing compounds every 24 hrs for 72 hrs relative to control	Plasmodium falciparum	1		organism-based format	Scientific Literature
14.	ALA4729159	F	Antimalarial activity against Plasmodium falciparum isolate GB002 assessed as reduction in parasitemia at 1 to 10 times EC50 supplemented with fresh medium containing compounds every 24 hrs for 72 hrs relative to control	Plasmodium falciparum	1		organism-based format	Scientific Literature
15.	ALA4729160	F	Antimalarial activity against Plasmodium falciparum isolate GB0026 assessed as reduction in parasitemia at 1 to 10 times EC50 supplemented with fresh medium containing compounds every 24 hrs for 72 hrs relative to control	Plasmodium falciparum	1		organism-based format	Scientific Literature
16.	ALA5251363	B	Inhibition of recombinant human CDK5/p25 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis	Homo sapiens	56		cell-based format	Scientific Literature
17.	ALA5251364	B	Inhibition of recombinant human CK1epsilon expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis	Homo sapiens	56		cell-based format	Scientific Literature
18.	ALA5251365	B	Inhibition of recombinant human CLK1 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis	Homo sapiens	56		cell-based format	Scientific Literature
19.	ALA5251366	B	Inhibition of recombinant human CLK2 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis	Homo sapiens	56		cell-based format	Scientific Literature
20.	ALA5251367	B	Inhibition of recombinant human CLK3 expressed in Sf9 insect cells incubated for 60 mins in presence of ATP and [gamma33-P] ATP by radiometric scintillation counter analysis	Homo sapiens	56		cell-based format	Scientific Literature